Richard A. Young, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 3,282 shares at $22.00 ($72K) on 2017-08-14, disclosed to the SEC on 2017-08-16.
Open-market sale of $72k SYRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OMGA | SELL | 2023-06-05 | $40K | — | Filing → |
| OMGA | SELL | 2023-05-03 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |